Besides, the regulation of PKM2 modulates inflammation by phosphorylating STAT3 and NF-κB in DKD that delays the differentiation of macrophages to M1 cells, and the downregulation of phosphorylated PKM2 is beneficial for DKD treatment (Li et al., 2020). Here, NFKB1 is linked to diabetic kidney disease.